Koivula T - Search Results

1

Promoter polymorphism of IL-10 and severity of multiple sclerosis.

Luomala M, Lehtimäki T, Huhtala H, Ukkonen M, Koivula T, Hurme M, Elovaara I. Luomala M, et al. Among authors: koivula t. Acta Neurol Scand. 2003 Dec;108(6):396-400. doi: 10.1034/j.1600-0404.2003.00165.x. Acta Neurol Scand. 2003. PMID: 14616291

2

Plasminogen activator inhibitor 1 gene and risk of MS in women.

Luomala M, Elovaara I, Ukkonen M, Koivula T, Lehtimäki T. Luomala M, et al. Among authors: koivula t. Neurology. 2000 May 9;54(9):1862-4. doi: 10.1212/wnl.54.9.1862. Neurology. 2000. PMID: 10802801

3

A study of interleukin-1 cluster genes in susceptibility to and severity of multiple sclerosis.

Luomala M, Lehtimäki T, Elovaara I, Wang X, Ukkonen M, Mattila K, Laippala P, Koivula T, Hurme M. Luomala M, et al. Among authors: koivula t. J Neurol Sci. 2001 Apr 1;185(2):123-7. doi: 10.1016/s0022-510x(01)00482-8. J Neurol Sci. 2001. PMID: 11311293

4

The association of myeloperoxidase promoter polymorphism with carotid atherosclerosis is abolished in patients with type 2 diabetes.

Mäkelä R, Loimaala A, Nenonen A, Mercuri M, Vuori I, Huhtala H, Oja P, Bond G, Koivula T, Lehtimäki T. Mäkelä R, et al. Among authors: koivula t. Clin Biochem. 2008 May;41(7-8):532-7. doi: 10.1016/j.clinbiochem.2008.01.017. Epub 2008 Feb 6. Clin Biochem. 2008. PMID: 18280811 Clinical Trial.

5

Relationship of the angiotensin-converting enzyme gene polymorphism to glucose intolerance, insulin resistance, and hypertension in NIDDM.

Huang XH, Rantalaiho V, Wirta O, Pasternack A, Koivula T, Hiltunen T, Nikkari T, Lehtimäki T. Huang XH, et al. Among authors: koivula t. Hum Genet. 1998 Mar;102(3):372-8. doi: 10.1007/s004390050707. Hum Genet. 1998. PMID: 9544854

6

Intercellular adhesion molecule-1 K/E 469 polymorphism and multiple sclerosis.

Luomala M, Elovaara I, Koivula T, Lehtimäki T. Luomala M, et al. Among authors: koivula t. Ann Neurol. 1999 Apr;45(4):546-7. doi: 10.1002/1531-8249(199904)45:4<546::aid-ana22>3.0.co;2-v. Ann Neurol. 1999. PMID: 10211485 No abstract available.

7

The combination of HLA-DR1 and HLA-DR53 protects against MS.

Luomala M, Elovaara I, Ukkonen M, Koivula T, Lehtimäki T. Luomala M, et al. Among authors: koivula t. Neurology. 2001 Feb 13;56(3):383-5. doi: 10.1212/wnl.56.3.383. Neurology. 2001. PMID: 11171905

8

Interaction between ESR1 and HLA-DR2 may contribute to the development of MS in women.

Mattila KM, Luomala M, Lehtimäki T, Laippala P, Koivula T, Elovaara I. Mattila KM, et al. Among authors: koivula t. Neurology. 2001 May 8;56(9):1246-7. doi: 10.1212/wnl.56.9.1246. Neurology. 2001. PMID: 11342704 No abstract available.

9

Paraoxonase producing PON1 gene M/L55 polymorphism is related to autopsy-verified artery-wall atherosclerosis.

Malin R, Järvinen O, Sisto T, Koivula T, Lehtimäki T. Malin R, et al. Among authors: koivula t. Atherosclerosis. 2001 Aug;157(2):301-7. doi: 10.1016/s0021-9150(00)00728-0. Atherosclerosis. 2001. PMID: 11472729

10

Coronary artery complicated lesion area is related to functional polymorphism of matrix metalloproteinase 9 gene: an autopsy study.

Pöllänen PJ, Karhunen PJ, Mikkelsson J, Laippala P, Perola M, Penttilä A, Mattila KM, Koivula T, Lehtimäki T. Pöllänen PJ, et al. Among authors: koivula t. Arterioscler Thromb Vasc Biol. 2001 Sep;21(9):1446-50. doi: 10.1161/hq0901.095545. Arterioscler Thromb Vasc Biol. 2001. PMID: 11557670

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

250 results

Search Page

Filters